Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

25 May 2016 - 27 May 2016
06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016

GE to Acquire Leading Manufacturer of Cell Culture Products

By BiotechDaily International staff writers
Posted on 22 Aug 2011
Print article
A developer and supplier of cell culture media for biomedical research and the fast-growing biopharmaceutical and vaccine-manufacturing industry is being acquired by GE, one of the world’s largest manufacturers of biomedical equipment and supplies.

PAA Laboratories (Pasching, Austria) recently announced that it is the final stages of becoming part of GE Healthcare (Little Chalfont, United Kingdom), a unit of General Electric Company (Fairfield, CT, USA).

PAA Laboratories develops and manufactures specialized and innovative cell culture products such as media, sera, growth supplements, and reagents for use in biomedical research and in the production of protein-based pharmaceuticals. The global demand for media, sera, and reagents for cell culture is predicted to grow from $2.3 billion in 2009 to an estimated $3.9 billion by 2015. PAA Laboratories, which maintains manufacturing facilities registered with the [US] Food and Drug Administration (FDA), has recently inaugurated an advanced manufacturing facility for powdered cell culture media to meet the growing demand for these products from the biopharmaceutical industry.

The acquisition of PAA Laboratories, which is expected to be completed in the third quarter of 2011, is consistent with GE's strategy to invest in high technology, innovative businesses that deliver strong top-line growth and expanded margins. “The acquisition of PAA Laboratories is a significant step forward for our Life Sciences business and for biopharmaceutical manufacturing globally,” said Kieran Murphy, president and CEO of GE Healthcare Life Sciences. “GE Healthcare Life Sciences is well known for its expertise in the “downstream” processes of biopharmaceutical manufacturing. Adding “upstream” capabilities will enable us to provide an end-to-end, fully integrated service to our customers. We believe that an integrated approach, where we can help customers optimize every stage of their manufacturing process, has the potential to reduce cost of entry, deliver higher yields of finished product, and reduce time to market.”

Rainer Burian, CEO of PAA Laboratories said, “This is a great opportunity for the professional team of staff at PAA Laboratories, and we are very excited to become part of GE Healthcare’s Life Sciences business. The Board of Directors of PAA Laboratories strongly believes that joining such a well-respected and recognized organization will give us significant opportunities to grow our business further with new technologies, products, and services. The entire PAA Laboratories team looks forward to joining GE.”

Related Links:
PAA Laboratories
GE Healthcare
General Electric Company


Print article

Channels

Genomics/Proteomics

view channel
Image: Follicular helper T-cells (TFH cells, shown in blue) play a crucial role in the maturation of antibody-producing B-cells (shown in green). Activated B-cells give rise germinal centers (shown in red), where mature B-cells proliferate and produce highly specific antibodies against pathogens. Top left: normal germinal center in a mouse tonsil. All others: Germinal centers fail to form when the interaction between ICOS and TBK1 is interrupted (Photo courtesy of Dr. Kok-Fai Kong, La Jolla Institute for Allergy and Immunology).

Molecular Pathway Controlling High-affinity Antibody Production Identified

A molecular pathway has been identified that controls formation of follicular helper T-cells (TFH cells) germinal centers and production of high-affinity antibodies through interaction with the inducible... Read more

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel

Huge Modifiable Biomedical Database to Be Available on the Wikidata Site

Genome researchers are exploiting the power of the open Internet community Wikipedia database to create a comprehensive resource for geneticists, molecular biologists, and other interested life scientists. While efficiency in generating scientific data improves almost daily, applying meaningful relationships between... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.